Page last updated: 2024-10-28

hydroxychloroquine and Myositis

hydroxychloroquine has been researched along with Myositis in 7 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Myositis: Inflammation of a muscle or muscle tissue.

Research Excerpts

ExcerptRelevanceReference
"In this study we investigated COVID-19 vaccination-related adverse events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory myopathies (IIMs) and other systemic autoimmune and inflammatory disorders (SAIDs)."1.72COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies. ( Agarwal, V; Aggarwal, R; Cavagna, L; Chatterjee, T; Chinoy, H; Day, J; Distler, O; Gaur, PS; Gheita, T; Gil-Vila, A; Gonzalez, RA; Gracia-Ramos, AE; Gupta, L; Joshi, M; Kardes, S; Kim, M; Knitza, J; Kuwana, M; Lilleker, JB; Makol, A; Milchert, M; Nikiphorou, E; Nune, A; Parodis, I; Ravichandran, N; Saavedra, MA; Salim, B; Selva-O'Callaghan, A; Sen, P; Shinjo, SK; Tan, AL; Velikova, T; Ziade, N, 2022)
"A control group of 16 patients with idiopathic inflammatory myositis (IIM) on HCQ at time of biopsy but without evidence of CB was identified."1.46Curvilinear bodies are associated with adverse effects on muscle function but not with hydroxychloroquine dosing. ( Blumbergs, P; Khoo, T; Koszyca, B; Lester, S; Limaye, V; Otto, S; Smith, C, 2017)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Gil-Vila, A1
Ravichandran, N1
Selva-O'Callaghan, A1
Sen, P1
Nune, A1
Gaur, PS1
Gonzalez, RA1
Lilleker, JB1
Joshi, M1
Agarwal, V2
Kardes, S1
Kim, M1
Day, J1
Makol, A1
Milchert, M1
Gheita, T1
Salim, B1
Velikova, T1
Gracia-Ramos, AE1
Parodis, I1
Nikiphorou, E1
Tan, AL1
Chatterjee, T1
Cavagna, L1
Saavedra, MA1
Shinjo, SK1
Ziade, N1
Knitza, J1
Kuwana, M1
Distler, O1
Chinoy, H1
Aggarwal, R1
Gupta, L1
Uslu, S1
Bozkirli, DE1
Kozanoglu, I1
Bozkirli, E1
Yucel, E1
Khoo, T1
Otto, S1
Smith, C1
Koszyca, B1
Lester, S1
Blumbergs, P1
Limaye, V1
LOUYOT, P1
GAUCHER, A1
JEANBLANC, J1
MONTET, Y1
Muirden, KD1
Ponge, T1
Mussini, JM1
Ponge, A1
Forgeau, Y1
Barrier, J1
Cottin, S1
Grolleau, JY1

Reviews

1 review available for hydroxychloroquine and Myositis

ArticleYear
The use of chloroquine and D-penicillamine in the treatment of rheumatoid arthritis.
    The Medical journal of Australia, 1986, Jan-06, Volume: 144, Issue:1

    Topics: Anti-Glomerular Basement Membrane Disease; Arthritis, Rheumatoid; Captopril; Chloroquine; Clinical T

1986

Trials

1 trial available for hydroxychloroquine and Myositis

ArticleYear
The use of chloroquine and D-penicillamine in the treatment of rheumatoid arthritis.
    The Medical journal of Australia, 1986, Jan-06, Volume: 144, Issue:1

    Topics: Anti-Glomerular Basement Membrane Disease; Arthritis, Rheumatoid; Captopril; Chloroquine; Clinical T

1986

Other Studies

6 other studies available for hydroxychloroquine and Myositis

ArticleYear
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies.
    Muscle & nerve, 2022, Volume: 66, Issue:4

    Topics: Adult; Animals; Autoimmune Diseases; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Exanthema; Female;

2022
Myositis due to COVID-19.
    Postgraduate medical journal, 2021, Volume: 97, Issue:1148

    Topics: Adult; Amides; Antiviral Agents; C-Reactive Protein; COVID-19; COVID-19 Nucleic Acid Testing; Creati

2021
Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
    Journal of clinical apheresis, 2013, Volume: 28, Issue:6

    Topics: Aged; Autoantibodies; Azathioprine; Combined Modality Therapy; Creatine Kinase; Cyclophosphamide; Em

2013
Curvilinear bodies are associated with adverse effects on muscle function but not with hydroxychloroquine dosing.
    Clinical rheumatology, 2017, Volume: 36, Issue:3

    Topics: Antirheumatic Agents; Databases, Factual; Humans; Hydroxychloroquine; Muscle Weakness; Muscle, Skele

2017
[EVALUATION OF LONG-TERM THERAPY WITH CHLOROQUINE AND HYDROXYCHLOROQUINE IN RHEUMATOLOGY].
    Rhumatologie, 1964, Volume: 16

    Topics: Arthritis; Arthritis, Rheumatoid; Chloroquine; Drug Therapy; Humans; Hydrarthrosis; Hydroxychloroqui

1964
[Primary Gougerot-Sjögren syndrome with necrotizing polymyositis: favorable effect of hydroxychloroquine].
    Revue neurologique, 1987, Volume: 143, Issue:2

    Topics: Female; Humans; Hydroxychloroquine; Middle Aged; Myositis; Sjogren's Syndrome

1987
chemdatabank.com